Freelite Human Lambda Free Kit (for use on the SPAPLUS) REF LK018.S Freelite Human Lambda Free K...
FDA Device Recall #Z-0274-2022 — Class II — October 15, 2021
Recall Summary
| Recall Number | Z-0274-2022 |
| Classification | Class II — Moderate risk |
| Date Initiated | October 15, 2021 |
| Status | Terminated |
| Voluntary | Voluntary: Firm initiated |
Recalling Firm
| Firm | The Binding Site Group, Ltd. |
| Location | Birmingham |
| Product Type | Devices |
| Quantity | 2,254 kits |
Product Description
Freelite Human Lambda Free Kit (for use on the SPAPLUS) REF LK018.S Freelite Human Lambda Free Kit (for use on the SPAPLUS) (x10) REF LK018.10S
Reason for Recall
Due to calibration curves producing a higher activity than routinely expected and that there may be a decrease in separation between calibrator point 5 and calibrator point 6, which can be exacerbated with calibrator 6 activity reaches the optical ceiling of the SPA+ analyzer.
Distribution Pattern
U.S.: CA, CO, FL, IL, IN, KY, LA, MI, NY, OK, SD, TX and VA. O.U.S.: Canada
Lot / Code Information
Model Number: LK018.S UDI Code: 05051700006477 Lot Number: 472776 Model Number:LK018.10S UDI Code: 05051700012201 Lot Number: 472664
Other Recalls from The Binding Site Group, Ltd.
| Recall # | Classification | Product | Date |
|---|---|---|---|
| Z-2030-2021 | Class II | FREELITE Human Kappa Free Kit for use on the Ro... | May 20, 2021 |
| Z-0943-2021 | Class II | Optilite Freelite Mx Kappa Free Kit REF LK016.... | Nov 18, 2020 |
| Z-2071-2020 | Class II | The Optilite Clinical Chemistry Analyzer. IVD. ... | Apr 9, 2020 |
| Z-1500-2020 | Class II | Rheumatoid Factor (RF) Kit for use on SPAPLUS, ... | Nov 6, 2019 |
| Z-2110-2020 | Class II | Optilite Optilite Rheumatoid Factor Kit, Ref: ... | Oct 7, 2019 |
Frequently Asked Questions
Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.
Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.
Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.
What Should You Do?
Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.